Water is not one endpoint.
Varun Sharma on the difference between a material taking up water, retaining it and earning a claim about skin.
Founder perspective | External research and proposed company work are distinguished.
Hydration needs a more exact question.
One familiar word can conceal several different experiments.
I want our polar-materials work to make the question clearer before making the answer bigger. When someone says a material is good with water, I want to know what was measured. Did a dry sample gain mass in a humid environment? Did a wet sample retain water? Did a deposited layer change a relevant response? Each possibility points towards a different development task.
The distinction is useful to a formulator because it shapes the next experiment. It is useful to an investor because it shows where a research observation still needs translation. It is useful to a reader because a compelling graph should explain what its curve can actually support.
Even the denominator changes the story. In an invented arithmetic example, a dry sample of 100 milligrams gaining 10 milligrams of water has gained 10 per cent of its dry starting mass. Water is approximately 9.1 per cent of the resulting total mass. Both numbers describe the same example. A reader needs the definition to know which comparison a reported percentage permits.
Examine the development decision
Water is not one endpoint.
Open the sequence to examine what a development decision needs.
Identify the exact preparation, its source, and the properties a second laboratory must be able to reproduce.
Explanatory geometry · no simulated or measured performance
Begin where the measurement begins.
The starting state belongs beside the result.
In the Sun et al. study, moisture absorption was assessed through mass gain of dried preparations under specified humidity conditions. Retention used a separate water-related endpoint and preparation context. These are experiments on the authors’ material, not measurements of a Bio product or human skin performance (Sun et al., 2015).
I would want a public analytical view to let a reader switch between those questions while keeping the sample, units and conditions visible. The interaction should help someone notice the distinction. Changing the colour of the same unexplained line would add movement without adding understanding.
I would want the preparation of the starting sample documented as carefully as the final weighing. What was defined as dry, what was initially present in the wet sample and what constituted the end of the observation? Where a paper leaves a condition ambiguous, the resource should retain that ambiguity. Turning it into a confident replication instruction would make the next experiment less reliable.
A measurement needs its definition.
A precise-looking value can still answer the wrong question.
My proposed starting point is a short measurement record: what quantity was measured, what sample was used, which conditions applied and how uncertainty was handled. Taylor and Kuyatt’s metrology guidance provides a framework for expressing measurement uncertainty; it does not validate a particular skin or materials test (Taylor and Kuyatt, 1994).
For Bio, the practical benefit is traceability. If another team questions a comparison, the discussion can return to its definition rather than relying on the impression created by a chart. That makes the evidence easier to improve and the public wording easier to keep proportionate.
The record should also distinguish variability in the material from uncertainty in observing it. Several readings of one sample do not necessarily reveal the variation between independently prepared samples. For a proposed package, I would ask which variation matters to the developer and how the design will examine it. A small error bar becomes useful when its basis is intelligible, not simply because it looks reassuring.
From a biological function to a material brief.
The application gives the science its next question.
A film is another development setting.
The next question is what happens after the mixture is applied.
Our intended polar-materials direction focuses on the behaviour of a deposited layer. A useful experimental brief would therefore connect preparation with application conditions and the chosen film endpoint. It would explain how the candidate is compared with the current alternative and which other formulation differences could affect interpretation.
I do not want to skip that work by borrowing a result from a powder test and giving it a product name. The possibility is more interesting when we can identify the actual transition being investigated: from a defined preparation to a layer with a potentially useful function.
A proposed film comparison should therefore describe the applied amount, the preparation of the supporting surface and the observation window. I would want the team to decide which of those details are held comparable and which are deliberately changed. That lets a result point towards an application condition or a material contribution, rather than leave the developer guessing which part of the experimental setting produced it.
A skin claim needs relevant support.
An application hypothesis and a consumer benefit have different evidence requirements.
The cosmetic-claims framework in Great Britain asks for evidence appropriate to the claim and makes the connection to the finished product important (OPSS, n.d.). That is a valuable discipline for a research-led company even before a product proposition is ready for such a claim.
I want the public site to distinguish an external observation, our interpretation and a proposed experiment. A reader can then see why the direction is worth investigating without being asked to believe that the application has already been proved. Clear boundaries make a serious development discussion easier to begin.
I would ask the team to write the intended statement before choosing the next study. If the statement concerns a deposited material, its supporting comparison should be designed for that setting. If it concerns a finished product used on skin, the evidence pathway has moved to another question. Working backwards from the intended conclusion makes the gap visible and gives the next package a reason.
Let the reader interrogate the comparison.
The best interaction would make an assumption visible.
Imagine selecting the endpoint, then seeing the relevant preparation and conditions stay attached to the values. Imagine an alternative explanation appearing beside the chart: different loading, a constituent travelling with the preparation or a limitation in the measurement. These would be reading aids, not predictions of Bio performance.
The next step could be a proposed comparison brief that records the uncertainty the reader has identified. For a formulation scientist, that makes the tool relevant to an experiment. For a commercial team, it makes the limitation relevant to what can responsibly be said about the material.
I would keep the comparison stable while the reader changes the view. Selecting a different endpoint should update its definition, not quietly substitute another denominator or material. A useful display could then show the question left unresolved and invite the reader to record it. The interaction becomes a bridge into scientific work: inspect the observation, identify the assumption and specify the comparison that could resolve it.
Precision gives ambition somewhere to go.
I want a clear endpoint to sharpen the opportunity.
If the useful effect is confined to a particular material state or condition, the application can be designed around that knowledge. If the effect does not survive a fair comparison, the programme can change direction with a reason. Both outcomes are more valuable than accumulating attractive charts that cannot guide the next commitment.
The invitation is to bring the water-related problem you actually need to resolve. Tell us the setting, the current material, the endpoint and the decision at stake. Then the discussion can move from a broad promise about hydration to a focused question worth testing.
That precision can change the commercial brief too. A prospective ingredient business may need to know which preparation merits application work; a formulation team may need to know which comparison fits its layer. A proposed first package should name that recipient and the decision it supports. The value is a more useful next commitment, rather than a larger claim assembled from endpoints that answer different questions.
The difference under investigation.
Turn the scientific question into a comparison with a useful output.
Evidence Observatory
Inside
the comparison.
Explore the published observations, their conditions and the next development question.
Examine the source dataDefine the endpoint that matters.
A short, non-confidential introduction can outline the application, the current approach, and where scientific input could help. Scope and next steps would be agreed around the actual project.
Discuss the development questionSources and reading notes.
External work is identified below. Access notes describe the material inspected for this page; company research questions and proposed work are not presented as findings from these sources.
Sun et al., 2015Sun, M.-L. et al. (2015) Characterization and Biotechnological Potential Analysis of a New Exopolysaccharide from the Arctic Marine Bacterium Polaribacter sp. SM1127. Scientific Reports, 5, 18435. doi:10.1038/srep18435.
Distinguishes crude EPS functional testing from further purified structural preparation; moisture absorption and retention experiments use specified material conditions.
Scope and limitations: External work on the authors’ preparations. Raw data, supplements and strain access were not reanalysed or secured. No Bio reproduction, skin efficacy, material ownership or commercial permission follows.
Open original sourceTaylor and Kuyatt, 1994Taylor, B.N. and Kuyatt, C.E. (1994) Guidelines for Evaluating and Expressing the Uncertainty of NIST Measurement Results. NIST Technical Note 1297.
Measurement results require an account of uncertainty and how it is evaluated and reported.
Scope and limitations: General metrology framework. Individual methods, instruments and uncertainty budgets require suitable scientific review; no Bio calibration or validation is implied.
Open original sourceOPSS, n.d.Office for Product Safety and Standards (n.d.) Regulation 1223/2009 and the Cosmetic Products Enforcement Regulations 2013: Great Britain. Article 20: Product Claims.
Cosmetic claims in Great Britain need an appropriate evidence basis and must not imply functions a finished product does not possess.
Scope and limitations: GB scope. Public research commentary is not legal advice, a finished cosmetic claim dossier, safety approval or evidence of Bio compliance.
Open original source
Film credits

